Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Naldemedine

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 86,335Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Shionogi and Ferrer sign an agreement for the promotion in Spain of Rizmoic® (naldemedine), a treatment for opioid-induced constipation
    Shionogi and Ferrer sign an agreement for the promotion in Spain of Rizmoic® (naldemedine), a treatment for opioid-induced constipation

    20 Jun 2019

    // PRESS RELEASE

    https://www.ferrer.com/es/node/49

    PRESS RELEASE
    20 Jun 2019
    Share Share
    SHIONOGI AND MOLTENI CONCLUDE A CONTRACT FOR THE COMMERCIALIZATION OF RIZMOIC®
    SHIONOGI AND MOLTENI CONCLUDE A CONTRACT FOR THE COMMERCIALIZATION OF RIZMOIC®

    22 May 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20190521005648/en

    BUSINESSWIRE
    22 May 2019
    Share Share
    Determination of Regulatory Review Period for Purposes of Patent Extension
    Determination of Regulatory Review Period for Purposes of Patent Extension

    15 Apr 2019

    // FEDERAL REGISTER

    https://www.federalregister.gov/documents/2019/04/15/2019-07459/determination-of-regulatory-review-period-for-purposes-of-patent-extension-symproic

    FEDERAL REGISTER
    15 Apr 2019
    Share Share
    Sandoz to commercialize Shionogi's Rizmoic in Germany, UK and Netherlands
    Sandoz to commercialize Shionogi's Rizmoic in Germany, UK and Netherlands

    11 Apr 2019

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=115178&sid=2

    PHARMABIZ
    11 Apr 2019
    Share Share
    Shionogi Concludes a Contract for the Commercialization of Rizmoic®
    Shionogi Concludes a Contract for the Commercialization of Rizmoic®

    11 Apr 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20190410005751/en

    BUSINESSWIRE
    11 Apr 2019
    Share Share
    Shionogi NV's Rizmoic (Naldemedine tosilate) Receives Approval in Europe
    Shionogi NV's Rizmoic (Naldemedine tosilate) Receives Approval in Europe

    23 Mar 2019

    // EMA

    https://www.ema.europa.eu/documents/overview/rizmoic-epar-medicine-overview_en.pdf

    EMA
    23 Mar 2019
    Share Share